Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ribavirin ANDAs Clear FDA; Schering Goes Generic Too

Apr 12 2004

• By The Pink Sheet

Related Content

Neurontin, Rebetol Generics Could Be Affected By “Shared Exclusivity” Ruling

Jan 12 2004

“Shared Exclusivity” Could Apply To Eight First-Time Generics, FDA Says

Feb 16 2004

Generic Ribavirin Label “Carve Out” Permitted; FDA Denies ICN Petition

Apr 12 2004

Ribavirin ANDAs Await Decision By FDA; Par, Roche Expect Launch In August

Jul 28 2003

Generic Ribavirin Labels Will Carve Out Rebetol/PEG-Intron Indication

Jul 21 2003

Schering PEG-Intron/Rebetol Phase IV To Evaluate Alternate Dosing Regimen

Aug 20 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window